103 related articles for article (PubMed ID: 8088401)
1. Involvement of calpain in myonephropathic metabolic syndrome (MNMS).
Tsuji Y; Kambayashi J; Shiba E; Sakon M; Kawasaki T; Mori T
Eur J Vasc Surg; 1994 Jul; 8(4):482-8. PubMed ID: 8088401
[TBL] [Abstract][Full Text] [Related]
2. [An experimental study of myonephropathic metabolic syndrome (MNMS)].
Onuki Y; Adachi S; Ando M; Takeuchi S; Nakajima N; Okui K
Nihon Geka Gakkai Zasshi; 1992 Feb; 93(2):197-207. PubMed ID: 1552892
[TBL] [Abstract][Full Text] [Related]
3. A free radical scavenger but not FGF-2-mediated angiogenic therapy rescues myonephropathic metabolic syndrome in severe hindlimb ischemia.
Kaneko K; Yonemitsu Y; Fujii T; Onimaru M; Jin CH; Inoue M; Hasegawa M; Onohara T; Maehara Y; Sueishi K
Am J Physiol Heart Circ Physiol; 2006 Apr; 290(4):H1484-92. PubMed ID: 16301206
[TBL] [Abstract][Full Text] [Related]
4. [Myonephropathic metabolic syndrome (MNMS)].
Shimai S; Takano T
Ryoikibetsu Shokogun Shirizu; 1996; (15):469-71. PubMed ID: 9048072
[No Abstract] [Full Text] [Related]
5. Effects of LTB4 receptor antagonist on myonephropathic metabolic syndrome: an experimental study.
Hayashi S
Kurume Med J; 2000; 47(1):63-72. PubMed ID: 10812891
[TBL] [Abstract][Full Text] [Related]
6. Inhibitors of calpain activation (PD150606 and E-64) and renal ischemia-reperfusion injury.
Chatterjee PK; Todorovic Z; Sivarajah A; Mota-Filipe H; Brown PA; Stewart KN; Mazzon E; Cuzzocrea S; Thiemermann C
Biochem Pharmacol; 2005 Apr; 69(7):1121-31. PubMed ID: 15763548
[TBL] [Abstract][Full Text] [Related]
7. Calpain Inhibitor Calpeptin Alleviates Ischemia/Reperfusion-Induced Acute Kidney Injury
Wu Y; Yang H; Cheng M; Shi J; Zhang W; Liu S; Zhang M
Front Med (Lausanne); 2022; 9():811980. PubMed ID: 35155498
[TBL] [Abstract][Full Text] [Related]
8. IL-17A contributes to brain ischemia reperfusion injury through calpain-TRPC6 pathway in mice.
Zhang J; Mao X; Zhou T; Cheng X; Lin Y
Neuroscience; 2014 Aug; 274():419-28. PubMed ID: 24928352
[TBL] [Abstract][Full Text] [Related]
9. Strategy for prevention of myonephropathic metabolic syndrome (MNMS): comparison of cooling and perfusion.
Oue H; Sugimoto T; Okada M
Kobe J Med Sci; 1999 Feb; 45(1):13-25. PubMed ID: 10487032
[TBL] [Abstract][Full Text] [Related]
10. Calpain inhibitor (BSF 409425) diminishes ischemia/reperfusion-induced damage of rabbit heart mitochondria.
Trumbeckaite S; Neuhof C; Zierz S; Gellerich FN
Biochem Pharmacol; 2003 Mar; 65(5):911-6. PubMed ID: 12628497
[TBL] [Abstract][Full Text] [Related]
11. Involvement of calpain isoforms in ischemia-reperfusion injury in rat retina.
Sakamoto YR; Nakajima TR; Fukiage CR; Sakai OR; Yoshida YR; Azuma MR; Shearer TR
Curr Eye Res; 2000 Jul; 21(1):571-80. PubMed ID: 11035539
[TBL] [Abstract][Full Text] [Related]
12. Proteasome participates in the pathogenesis of ischemic acute renal failure in rats.
Takaoka M; Itoh M; Hayashi S; Kuro T; Matsumura Y
Eur J Pharmacol; 1999 Nov; 384(1):43-6. PubMed ID: 10611418
[TBL] [Abstract][Full Text] [Related]
13. The effects of calpeptin (a calpain specific inhibitor) on agonist induced microparticle formation from the platelet plasma membrane.
Yano Y; Shiba E; Kambayashi J; Sakon M; Kawasaki T; Fujitani K; Kang J; Mori T
Thromb Res; 1993 Sep; 71(5):385-96. PubMed ID: 8236165
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of focal adhesion kinase against skeletal muscle reperfusion injury after acute limb ischemia.
Flück M; von Allmen RS; Ferrié C; Tevaearai H; Dick F
Eur J Vasc Endovasc Surg; 2015 Mar; 49(3):306-13. PubMed ID: 25556082
[TBL] [Abstract][Full Text] [Related]
15. Determinants of ischemic injury to skeletal muscle.
Petrasek PF; Homer-Vanniasinkam S; Walker PM
J Vasc Surg; 1994 Apr; 19(4):623-31. PubMed ID: 8164277
[TBL] [Abstract][Full Text] [Related]
16. Determination of a safe vascular clamping method for liver surgery: evaluation by measuring activation of calpain mu.
Wang M; Sakon M; Umeshita K; Miyoshi H; Taniguchi K; Kishimoto S; Imajoh-Ohmi S; Monden M
Arch Surg; 1998 Sep; 133(9):983-7. PubMed ID: 9749852
[TBL] [Abstract][Full Text] [Related]
17. Characterization of systemic and histologic injury after crush syndrome and intervals of reperfusion in a small animal model.
Murata I; Ooi K; Sasaki H; Kimura S; Ohtake K; Ueda H; Uchida H; Yasui N; Tsutsui Y; Yoshizawa N; Hirotsu I; Morimoto Y; Kobayashi J
J Trauma; 2011 Jun; 70(6):1453-63. PubMed ID: 21817983
[TBL] [Abstract][Full Text] [Related]
18. Correlation of ischemia/reperfusion or partial outlet obstruction-induced spectrin proteolysis by calpain with contractile dysfunction in rabbit bladder.
Zhao Y; Levin SS; Wein AJ; Levin RM
Urology; 1997 Feb; 49(2):293-300. PubMed ID: 9037302
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of calpain in the growth of estrogen receptor positive breast cancer cells.
Shiba E; Kim S; Fujitani M; Kambayashi JI; Kawamura I; Tsujimoto S; Shimomura K; Tanji Y; Taguchi T; Kimoto Y; Izukura M; Takai SI
Anticancer Res; 1996; 16(2):773-7. PubMed ID: 8687127
[TBL] [Abstract][Full Text] [Related]
20. Calpain inhibitor-1 reduces renal ischemia/reperfusion injury in the rat.
Chatterjee PK; Brown PA; Cuzzocrea S; Zacharowski K; Stewart KN; Mota-Filipe H; McDonald MC; Thiemermann C
Kidney Int; 2001 Jun; 59(6):2073-83. PubMed ID: 11380809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
